Gut Microbiota–Platelet Axis and Thrombosis in Advanced Chronic Liver Disease
Thrombosis and Haemostasis · 01.05.2026 · 126 (05) · 445-454
DOI: 10.1055/a-2628-4143 ↗Kurz gefasst
Übersichtsarbeit in der Zeitschrift Thrombosis and Haemostasis, erschienen am 01.05.2026. Verfasst von Francesco Violi und 3 weiteren Autor:innen. Beteiligte Einrichtung: Sapienza University of Rome, Rome, Italy. Hauptthemen laut MEDLINE: Gastrointestinal Microbiome, Blood Platelets, Platelet Activation, Liver Diseases. Die Arbeit wurde bisher 1-mal zitiert (Crossref) und nennt 79 Literaturangaben.
Abstract (Originalsprache)
Advanced chronic liver disease is characterized by metabolic-associated liver disease, metabolic-associated steatohepatitis, and cirrhosis. This clinical setting is associated with platelet activation, which has been suggested to play a role in the progression of liver disease; thus, platelet activation has been detected in portal circulation as well within liver sinusoids. Experimental studies with antiplatelet drugs and observational studies in human suggested a role for platelet activation in the mechanism of the disease. Furthermore, advanced chronic liver disease may be complicated by atherosclerotic complications, where the role of platelet activation is well consolidated. Platelet activation may represent a unique mechanism leading to liver disease on one hand and to atherosclerotic complications on the other hand. Several studies pointed to the role of gut dysbiosis as key step for eliciting platelet activation via the production of pro-aggregating metabolites such as trimethylamine N-oxide or translocation of bacterial products such as lipopolysaccharide into the systemic circulation. The aims of this narrative review are to show the experimental and clinical evidence relating platelets with advanced chronic liver disease, to explore the role of gut microbiota as mechanism for platelet activation, and to suggest novel therapeutic strategies to inhibit gut microbiota–platelet axis.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Substanzen
Autor:innen und Institutionen
- Sapienza University of Rome, Rome, Italy.
- Department of Clinical, Internal Medicine, Anesthesiological and Cardiovascular Sciences, Sapienza University of Rome, Rome, Italy.
- Department of General Surgery and Surgical Speciality, Sapienza University of Rome, Rome, Italy.
- Department of Infectious Disease, Umberto I Hospital, Rome, Italy.
ORCID-Profile: Francesco Violi, Emanuele Valeriani
Zitieren
APA
Violi, F., Cammisotto, V., Pignatelli, P., & Valeriani, E. (2026). Gut Microbiota–Platelet Axis and Thrombosis in Advanced Chronic Liver Disease. Thrombosis and Haemostasis, 126(05), 445-454. https://doi.org/10.1055/a-2628-4143
Vancouver
Violi F, Cammisotto V, Pignatelli P, Valeriani E. Gut Microbiota–Platelet Axis and Thrombosis in Advanced Chronic Liver Disease. Thrombosis and Haemostasis. 2026;126(05):445-454. doi:10.1055/a-2628-4143
BibTeX
@article{Violi2026,
author = {Violi, Francesco and Cammisotto, Vittoria and Pignatelli, Pasquale and Valeriani, Emanuele},
title = {Gut Microbiota–Platelet Axis and Thrombosis in Advanced Chronic Liver Disease},
journal = {Thrombosis and Haemostasis},
year = {2026},
volume = {126},
number = {05},
pages = {445--454},
doi = {10.1055/a-2628-4143}
}
EUVIMED